Objective: to study the analgesic and anti-inflammatory effect of clomipramine.
目的：研究氯丙米嗪镇痛抗炎作用。
Antidepressants are most commonly used, including doxepin, amitriptyline, fluoxetine, and clomipramine.
抗抑郁药物是最常用的，包括多虑平、阿米替林、氟西汀和氯米帕明。
OBJECTIVE: To compare the efficacy and side effects of sertraline and clomipramine in treatment of OCD.
目的：比较舍曲林和氯丙咪嗪治疗强迫症的疗效和不良反应。
Conclusions: Both clomipramine and fluoxetine are effective in treatment of child depression with few side effects.
结论：氯丙咪嗪和氟西汀治疗儿童抑郁症都疗效明显和安全性较高。
Objective:To compare the efficacy and side effects of clomipramine and fluoxetine in treatment of childhood depression.
目的：比较氯丙咪嗪和氟西汀治疗儿童抑郁症的疗效和安全性。
Objective To explore the curative effects and safety of venlafaxine and clomipramine in anxiety and depression comorbidity.
目的探讨万拉法新与氯米帕明治疗焦虑抑郁障碍共病的疗效及安全性。
Objective Fluvoxamine and clomipramine in the treatment of obsessive-compulsive disorder and the effects of adverse reactions.
目的比较氟伏沙明与氯米帕明治疗强迫症的疗效和不良反应。
Objective: To compare the efficacy and side effect of Paroxetine versus Clomipramine in treatment of obsessive compulsive neurosis.
目的：比较帕罗西汀与氯丙咪嗪治疗强迫症的疗效和副反应。
Objective To compare the efficacy and side effects of fluoxetine with clomipramine in treating 60 refractory obsessive - compulsive patients.
目的评价氟西汀和氯米帕明对难治性强迫症的疗效。
Objective To compare the efficacy and security of citalopram and clomipramine in the treatment of depression, anxiety in cervical disc herniation patients.
目的比较西酞普兰与氯丙咪嗪治疗颈椎间盘突出症伴抑郁焦虑症状的疗效和不良反应。
Standard, first-line OCD treatment typically includes selective serotonin-reuptake inhibitors (SSRIs) and tricyclic antidepressants such as clomipramine, along with behavioral therapies.
标准治疗就是使用一线OCD治疗药物包括选择性5-羟色胺再吸收抑制剂和三环抗抑郁药如氯丙咪嗪再加上行为治疗。
Conclusion Venlafaxine has equivalent curative effect to clomipramine in the treatment of anxiety and depression comorbidity, takes effect faster, and has higher safety and better compliance.
结论万拉法新治疗焦虑抑郁障碍共病疗效与氯米帕明相当，但起效时间较氯米帕明快，且安全性高，依从性好。
Conclusion Venlafaxine has equivalent curative effect to clomipramine in the treatment of anxiety and depression comorbidity, takes effect faster, and has higher safety and better compliance.
结论万拉法新治疗焦虑抑郁障碍共病疗效与氯米帕明相当，但起效时间较氯米帕明快，且安全性高，依从性好。
应用推荐